Cited In for PMID: 19411172

Year	Number of Results
2009	1
2010	4
2011	1
2012	2
2013	1
2014	1
2018	1
2024	0

1

Arnett AL, Chamberlain JR, Chamberlain JS. Arnett AL, et al. Curr Opin Genet Dev. 2009 Jun;19(3):290-7. doi: 10.1016/j.gde.2009.03.005. Epub 2009 May 4. Curr Opin Genet Dev. 2009. PMID: 19411172 Review.

2

At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?

Gawlik KI. Gawlik KI. Int J Mol Sci. 2018 May 16;19(5):1490. doi: 10.3390/ijms19051490. Int J Mol Sci. 2018. PMID: 29772730 Free PMC article. Review.

3

Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).

Sancisi V, Germinario E, Esposito A, Morini E, Peron S, Moggio M, Tomelleri G, Danieli-Betto D, Tupler R. Sancisi V, et al. Am J Physiol Regul Integr Comp Physiol. 2014 Jan 15;306(2):R124-37. doi: 10.1152/ajpregu.00379.2013. Epub 2013 Dec 4. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 24305066 Free PMC article.

4

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL. Seto JT, et al. Curr Gene Ther. 2012 Jun;12(3):139-51. doi: 10.2174/156652312800840603. Curr Gene Ther. 2012. PMID: 22533379 Free PMC article. Review.

5

Animal models of muscular dystrophy.

Ng R, Banks GB, Hall JK, Muir LA, Ramos JN, Wicki J, Odom GL, Konieczny P, Seto J, Chamberlain JR, Chamberlain JS. Ng R, et al. Prog Mol Biol Transl Sci. 2012;105:83-111. doi: 10.1016/B978-0-12-394596-9.00004-4. Prog Mol Biol Transl Sci. 2012. PMID: 22137430 Free PMC article. Review.

6

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector.

Arnett AL, Garikipati D, Wang Z, Tapscott S, Chamberlain JS. Arnett AL, et al. Front Microbiol. 2011 Nov 3;2:220. doi: 10.3389/fmicb.2011.00220. eCollection 2011. Front Microbiol. 2011. PMID: 22065964 Free PMC article.

7

The genetic basis of non-syndromic intellectual disability: a review.

Kaufman L, Ayub M, Vincent JB. Kaufman L, et al. J Neurodev Disord. 2010 Dec;2(4):182-209. doi: 10.1007/s11689-010-9055-2. Epub 2010 Jul 29. J Neurodev Disord. 2010. PMID: 21124998 Free PMC article.

8

Progress in muscular dystrophy research with special emphasis on gene therapy.

Sugita H, Takeda S. Sugita H, et al. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(7):748-56. doi: 10.2183/pjab.86.748. Proc Jpn Acad Ser B Phys Biol Sci. 2010. PMID: 20689232 Free PMC article. Review.

9

A First Step in Viral Gene Therapy for Muscular Dystrophy.

Hirano M. Hirano M. Curr Neurol Neurosci Rep. 2010 Mar;10(2):71-72. doi: 10.1007/s11910-010-0090-x. Curr Neurol Neurosci Rep. 2010. PMID: 20651902 Free PMC article. No abstract available.

10

Muscling in: Gene therapies for muscular dystrophy target RNA.

Chamberlain JR, Chamberlain JS. Chamberlain JR, et al. Nat Med. 2010 Feb;16(2):170-1. doi: 10.1038/nm0210-170. Nat Med. 2010. PMID: 20134472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year